http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 04 Jun 2026 08:02:38 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/Dare+Bioscience+launches+Flora+Sync+LF5+vaginal+probiotic+capsules/26602776.html <p>Daré Bioscience Inc. (NASDAQ: DARE) announced the commercial launch of Flora Sync LF5, a vaginal probiotic capsule designed to restore microbiome balance. The company expects to generate its first direct consumer product revenue in June 2026.</p><p>Flora Sync LF5 contains Limosilactobacillus fermentum LF5, a probiotic strain isolated from the vaginal microbiome of healthy women. The product will be priced at $49 per box containing six capsules and is designed as a three-day treatment routine.</p><p>"Flora Sync LF5 was developed specifically for vaginal health, not gut health," said Sabrina Martucci Johnson, President and Chief Executive Officer of Daré Bioscience. "This upcoming launch marks http://www.streetinsider.com/Corporate+News/Dare+Bioscience+launches+Flora+Sync+LF5+vaginal+probiotic+capsules/26602776.html Thu, 04 Jun 2026 08:02:38 -0400 DARE http://www.streetinsider.com/Press+Releases/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html <p align="center"><strong>First Product Revenue Expected This Month, Opening New Commercial Chapter for Women&apos;s Health Innovator</strong></p> <p align="center"><strong>Limited-Time Launch Offer: 30% Off + Free Shipping </strong></p> <p align="justify">SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&apos;s health between promising science and real-world solutions, today announced the upcoming commercial launch of <strong>Flora Sync LF5</strong>™, a vaginal probiotic capsule formulated specifically to restore microbiome balance and support lasting vaginal comfort. The launch represents a milestone for Daré, as the company expects to generate http://www.streetinsider.com/Press+Releases/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html Thu, 04 Jun 2026 08:00:00 -0400 A.06822034 A.50204978 A.50207596 A.50208593 DARE O.00303771 O.00531298 O.00645197 O.02823105 O.20026344 http://www.streetinsider.com/Press+Releases/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html <p align="center"><strong>First Product Revenue Expected This Month, Opening New Commercial Chapter for Women&apos;s Health Innovator</strong></p> <p align="center"><strong>Limited-Time Launch Offer: 30% Off + Free Shipping </strong></p> <p align="justify">SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&apos;s health between promising science and real-world solutions, today announced the upcoming commercial launch of <strong>Flora Sync LF5</strong>™, a vaginal probiotic capsule formulated specifically to restore microbiome balance and support lasting vaginal comfort. The launch represents a milestone for Daré, as the company expects to generate http://www.streetinsider.com/Press+Releases/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html Thu, 04 Jun 2026 08:00:00 -0400 A.06822034 A.50204978 A.50207596 A.50208593 DARE O.00303771 O.00531298 O.00645197 O.02823105 O.20026344 http://www.streetinsider.com/Press+Releases/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html <p align="center"><strong>First Product Revenue Expected This Month, Opening New Commercial Chapter for Women&apos;s Health Innovator</strong></p> <p align="center"><strong>Limited-Time Launch Offer: 30% Off + Free Shipping </strong></p> <p align="justify">SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&apos;s health between promising science and real-world solutions, today announced the upcoming commercial launch of <strong>Flora Sync LF5</strong>™, a vaginal probiotic capsule formulated specifically to restore microbiome balance and support lasting vaginal comfort. The launch represents a milestone for Daré, as the company expects to generate http://www.streetinsider.com/Press+Releases/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html Thu, 04 Jun 2026 08:00:00 -0400 A.06822034 A.50204978 A.50207596 A.50208593 DARE O.00303771 O.00531298 O.00645197 O.02823105 O.20026344 http://www.streetinsider.com/Press+Releases/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html <p align="center"><strong>First Product Revenue Expected This Month, Opening New Commercial Chapter for Women&apos;s Health Innovator</strong></p> <p align="center"><strong>Limited-Time Launch Offer: 30% Off + Free Shipping </strong></p> <p align="justify">SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&apos;s health between promising science and real-world solutions, today announced the upcoming commercial launch of <strong>Flora Sync LF5</strong>™, a vaginal probiotic capsule formulated specifically to restore microbiome balance and support lasting vaginal comfort. The launch represents a milestone for Daré, as the company expects to generate http://www.streetinsider.com/Press+Releases/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html Thu, 04 Jun 2026 08:00:00 -0400 A.06822034 A.50204978 A.50207596 A.50208593 DARE O.00303771 O.00531298 O.00645197 O.02823105 O.20026344 http://www.streetinsider.com/Press+Releases/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html <p align="center"><strong>First Product Revenue Expected This Month, Opening New Commercial Chapter for Women&apos;s Health Innovator</strong></p> <p align="center"><strong>Limited-Time Launch Offer: 30% Off + Free Shipping </strong></p> <p align="justify">SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&apos;s health between promising science and real-world solutions, today announced the upcoming commercial launch of <strong>Flora Sync LF5</strong>™, a vaginal probiotic capsule formulated specifically to restore microbiome balance and support lasting vaginal comfort. The launch represents a milestone for Daré, as the company expects to generate http://www.streetinsider.com/Press+Releases/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html Thu, 04 Jun 2026 08:00:00 -0400 A.06822034 A.50204978 A.50207596 A.50208593 DARE O.00303771 O.00531298 O.00645197 O.02823105 O.20026344 http://www.streetinsider.com/Press+Releases/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html <p align="center"><strong>First Product Revenue Expected This Month, Opening New Commercial Chapter for Women&apos;s Health Innovator</strong></p> <p align="center"><strong>Limited-Time Launch Offer: 30% Off + Free Shipping </strong></p> <p align="justify">SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&apos;s health between promising science and real-world solutions, today announced the upcoming commercial launch of <strong>Flora Sync LF5</strong>™, a vaginal probiotic capsule formulated specifically to restore microbiome balance and support lasting vaginal comfort. The launch represents a milestone for Daré, as the company expects to generate http://www.streetinsider.com/Press+Releases/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html Thu, 04 Jun 2026 08:00:00 -0400 A.06822034 A.50204978 A.50207596 A.50208593 DARE O.00303771 O.00531298 O.00645197 O.02823105 O.20026344 http://www.streetinsider.com/Press+Releases/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html <p align="center"><strong>First Product Revenue Expected This Month, Opening New Commercial Chapter for Women&apos;s Health Innovator</strong></p> <p align="center"><strong>Limited-Time Launch Offer: 30% Off + Free Shipping </strong></p> <p align="justify">SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&apos;s health between promising science and real-world solutions, today announced the upcoming commercial launch of <strong>Flora Sync LF5</strong>™, a vaginal probiotic capsule formulated specifically to restore microbiome balance and support lasting vaginal comfort. The launch represents a milestone for Daré, as the company expects to generate http://www.streetinsider.com/Press+Releases/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html Thu, 04 Jun 2026 08:00:00 -0400 A.06822034 A.50204978 A.50207596 A.50208593 DARE O.00303771 O.00531298 O.00645197 O.02823105 O.20026344 http://www.streetinsider.com/Press+Releases/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html <p align="center"><strong>First Product Revenue Expected This Month, Opening New Commercial Chapter for Women&apos;s Health Innovator</strong></p> <p align="center"><strong>Limited-Time Launch Offer: 30% Off + Free Shipping </strong></p> <p align="justify">SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&apos;s health between promising science and real-world solutions, today announced the upcoming commercial launch of <strong>Flora Sync LF5</strong>™, a vaginal probiotic capsule formulated specifically to restore microbiome balance and support lasting vaginal comfort. The launch represents a milestone for Daré, as the company expects to generate http://www.streetinsider.com/Press+Releases/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html Thu, 04 Jun 2026 08:00:00 -0400 A.06822034 A.50204978 A.50207596 A.50208593 DARE O.00303771 O.00531298 O.00645197 O.02823105 O.20026344 http://www.streetinsider.com/Press+Releases/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html <p align="center"><strong>First Product Revenue Expected This Month, Opening New Commercial Chapter for Women&apos;s Health Innovator</strong></p> <p align="center"><strong>Limited-Time Launch Offer: 30% Off + Free Shipping </strong></p> <p align="justify">SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&apos;s health between promising science and real-world solutions, today announced the upcoming commercial launch of <strong>Flora Sync LF5</strong>™, a vaginal probiotic capsule formulated specifically to restore microbiome balance and support lasting vaginal comfort. The launch represents a milestone for Daré, as the company expects to generate http://www.streetinsider.com/Press+Releases/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html Thu, 04 Jun 2026 08:00:00 -0400 A.06822034 A.50204978 A.50207596 A.50208593 DARE O.00303771 O.00531298 O.00645197 O.02823105 O.20026344 http://www.streetinsider.com/Press+Releases/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html <p align="center"><strong>First Product Revenue Expected This Month, Opening New Commercial Chapter for Women&apos;s Health Innovator</strong></p> <p align="center"><strong>Limited-Time Launch Offer: 30% Off + Free Shipping </strong></p> <p align="justify">SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&apos;s health between promising science and real-world solutions, today announced the upcoming commercial launch of <strong>Flora Sync LF5</strong>™, a vaginal probiotic capsule formulated specifically to restore microbiome balance and support lasting vaginal comfort. The launch represents a milestone for Daré, as the company expects to generate http://www.streetinsider.com/Press+Releases/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html Thu, 04 Jun 2026 08:00:00 -0400 A.06822034 A.50204978 A.50207596 A.50208593 DARE O.00303771 O.00531298 O.00645197 O.02823105 O.20026344 http://www.streetinsider.com/Globe+Newswire/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html <p align="center"><strong>First Product Revenue Expected This Month, Opening New Commercial Chapter for Women&apos;s Health Innovator</strong></p> <p align="center"><strong>Limited-Time Launch Offer: 30% Off + Free Shipping </strong></p> <p align="justify">SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&apos;s health between promising science and real-world solutions, today announced the upcoming commercial launch of <strong>Flora Sync LF5</strong>™, a vaginal probiotic capsule formulated specifically to restore microbiome balance and support lasting vaginal comfort. The launch represents a milestone for Daré, as the company expects to generate http://www.streetinsider.com/Globe+Newswire/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html Thu, 04 Jun 2026 08:00:00 -0400 A.06822034 A.50204978 A.50207596 A.50208593 DARE O.00303771 O.00531298 O.00645197 O.02823105 O.20026344 http://www.streetinsider.com/Globe+Newswire/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html <p align="center"><strong>First Product Revenue Expected This Month, Opening New Commercial Chapter for Women&apos;s Health Innovator</strong></p> <p align="center"><strong>Limited-Time Launch Offer: 30% Off + Free Shipping </strong></p> <p align="justify">SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&apos;s health between promising science and real-world solutions, today announced the upcoming commercial launch of <strong>Flora Sync LF5</strong>™, a vaginal probiotic capsule formulated specifically to restore microbiome balance and support lasting vaginal comfort. The launch represents a milestone for Daré, as the company expects to generate http://www.streetinsider.com/Globe+Newswire/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html Thu, 04 Jun 2026 08:00:00 -0400 A.06822034 A.50204978 A.50207596 A.50208593 DARE O.00303771 O.00531298 O.00645197 O.02823105 O.20026344 http://www.streetinsider.com/Globe+Newswire/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html <p align="center"><strong>First Product Revenue Expected This Month, Opening New Commercial Chapter for Women&apos;s Health Innovator</strong></p> <p align="center"><strong>Limited-Time Launch Offer: 30% Off + Free Shipping </strong></p> <p align="justify">SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&apos;s health between promising science and real-world solutions, today announced the upcoming commercial launch of <strong>Flora Sync LF5</strong>™, a vaginal probiotic capsule formulated specifically to restore microbiome balance and support lasting vaginal comfort. The launch represents a milestone for Daré, as the company expects to generate http://www.streetinsider.com/Globe+Newswire/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html Thu, 04 Jun 2026 08:00:00 -0400 A.06822034 A.50204978 A.50207596 A.50208593 DARE O.00303771 O.00531298 O.00645197 O.02823105 O.20026344 http://www.streetinsider.com/Globe+Newswire/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html <p align="center"><strong>First Product Revenue Expected This Month, Opening New Commercial Chapter for Women&apos;s Health Innovator</strong></p> <p align="center"><strong>Limited-Time Launch Offer: 30% Off + Free Shipping </strong></p> <p align="justify">SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&apos;s health between promising science and real-world solutions, today announced the upcoming commercial launch of <strong>Flora Sync LF5</strong>™, a vaginal probiotic capsule formulated specifically to restore microbiome balance and support lasting vaginal comfort. The launch represents a milestone for Daré, as the company expects to generate http://www.streetinsider.com/Globe+Newswire/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html Thu, 04 Jun 2026 08:00:00 -0400 A.06822034 A.50204978 A.50207596 A.50208593 DARE O.00303771 O.00531298 O.00645197 O.02823105 O.20026344 http://www.streetinsider.com/Globe+Newswire/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html <p align="center"><strong>First Product Revenue Expected This Month, Opening New Commercial Chapter for Women&apos;s Health Innovator</strong></p> <p align="center"><strong>Limited-Time Launch Offer: 30% Off + Free Shipping </strong></p> <p align="justify">SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&apos;s health between promising science and real-world solutions, today announced the upcoming commercial launch of <strong>Flora Sync LF5</strong>™, a vaginal probiotic capsule formulated specifically to restore microbiome balance and support lasting vaginal comfort. The launch represents a milestone for Daré, as the company expects to generate http://www.streetinsider.com/Globe+Newswire/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html Thu, 04 Jun 2026 08:00:00 -0400 A.06822034 A.50204978 A.50207596 A.50208593 DARE O.00303771 O.00531298 O.00645197 O.02823105 O.20026344 http://www.streetinsider.com/Globe+Newswire/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html <p align="center"><strong>First Product Revenue Expected This Month, Opening New Commercial Chapter for Women&apos;s Health Innovator</strong></p> <p align="center"><strong>Limited-Time Launch Offer: 30% Off + Free Shipping </strong></p> <p align="justify">SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&apos;s health between promising science and real-world solutions, today announced the upcoming commercial launch of <strong>Flora Sync LF5</strong>™, a vaginal probiotic capsule formulated specifically to restore microbiome balance and support lasting vaginal comfort. The launch represents a milestone for Daré, as the company expects to generate http://www.streetinsider.com/Globe+Newswire/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html Thu, 04 Jun 2026 08:00:00 -0400 A.06822034 A.50204978 A.50207596 A.50208593 DARE O.00303771 O.00531298 O.00645197 O.02823105 O.20026344 http://www.streetinsider.com/Globe+Newswire/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html <p align="center"><strong>First Product Revenue Expected This Month, Opening New Commercial Chapter for Women&apos;s Health Innovator</strong></p> <p align="center"><strong>Limited-Time Launch Offer: 30% Off + Free Shipping </strong></p> <p align="justify">SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&apos;s health between promising science and real-world solutions, today announced the upcoming commercial launch of <strong>Flora Sync LF5</strong>™, a vaginal probiotic capsule formulated specifically to restore microbiome balance and support lasting vaginal comfort. The launch represents a milestone for Daré, as the company expects to generate http://www.streetinsider.com/Globe+Newswire/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html Thu, 04 Jun 2026 08:00:00 -0400 A.06822034 A.50204978 A.50207596 A.50208593 DARE O.00303771 O.00531298 O.00645197 O.02823105 O.20026344 http://www.streetinsider.com/Globe+Newswire/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html <p align="center"><strong>First Product Revenue Expected This Month, Opening New Commercial Chapter for Women&apos;s Health Innovator</strong></p> <p align="center"><strong>Limited-Time Launch Offer: 30% Off + Free Shipping </strong></p> <p align="justify">SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&apos;s health between promising science and real-world solutions, today announced the upcoming commercial launch of <strong>Flora Sync LF5</strong>™, a vaginal probiotic capsule formulated specifically to restore microbiome balance and support lasting vaginal comfort. The launch represents a milestone for Daré, as the company expects to generate http://www.streetinsider.com/Globe+Newswire/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html Thu, 04 Jun 2026 08:00:00 -0400 A.06822034 A.50204978 A.50207596 A.50208593 DARE O.00303771 O.00531298 O.00645197 O.02823105 O.20026344 http://www.streetinsider.com/Globe+Newswire/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html <p align="center"><strong>First Product Revenue Expected This Month, Opening New Commercial Chapter for Women&apos;s Health Innovator</strong></p> <p align="center"><strong>Limited-Time Launch Offer: 30% Off + Free Shipping </strong></p> <p align="justify">SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&apos;s health between promising science and real-world solutions, today announced the upcoming commercial launch of <strong>Flora Sync LF5</strong>™, a vaginal probiotic capsule formulated specifically to restore microbiome balance and support lasting vaginal comfort. The launch represents a milestone for Daré, as the company expects to generate http://www.streetinsider.com/Globe+Newswire/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html Thu, 04 Jun 2026 08:00:00 -0400 A.06822034 A.50204978 A.50207596 A.50208593 DARE O.00303771 O.00531298 O.00645197 O.02823105 O.20026344 http://www.streetinsider.com/Globe+Newswire/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html <p align="center"><strong>First Product Revenue Expected This Month, Opening New Commercial Chapter for Women&apos;s Health Innovator</strong></p> <p align="center"><strong>Limited-Time Launch Offer: 30% Off + Free Shipping </strong></p> <p align="justify">SAN DIEGO, June 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women&apos;s health between promising science and real-world solutions, today announced the upcoming commercial launch of <strong>Flora Sync LF5</strong>™, a vaginal probiotic capsule formulated specifically to restore microbiome balance and support lasting vaginal comfort. The launch represents a milestone for Daré, as the company expects to generate http://www.streetinsider.com/Globe+Newswire/Dar%C3%A9+Bioscience+Announces+the+Upcoming+Launch+of+Flora+Sync+LF5%E2%84%A2+Vaginal+Probiotic+Capsules/26602688.html Thu, 04 Jun 2026 08:00:00 -0400 A.06822034 A.50204978 A.50207596 A.50208593 DARE O.00303771 O.00531298 O.00645197 O.02823105 O.20026344 http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Dare+Bioscience%2C+Inc.++++++++++++++++/26585020.html si-local-file:///var/storage/secattach/20260601/26585020.html http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Dare+Bioscience%2C+Inc.++++++++++++++++/26585020.html Mon, 01 Jun 2026 17:15:00 -0400 DARE O.02823105 http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Dare+Bioscience%2C+Inc.++++++++++++++++/26585020.html si-local-file:///var/storage/secattach/20260601/26585020.html http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Dare+Bioscience%2C+Inc.++++++++++++++++/26585020.html Mon, 01 Jun 2026 17:15:00 -0400 DARE O.02823105 http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Dare+Bioscience%2C+Inc.++++++++++++++++/26580286.html si-local-file:///var/storage/secattach/20260601/26580286.html http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Dare+Bioscience%2C+Inc.++++++++++++++++/26580286.html Mon, 01 Jun 2026 09:00:00 -0400 DARE O.02823105 http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Dare+Bioscience%2C+Inc.++++++++++++++++/26580286.html si-local-file:///var/storage/secattach/20260601/26580286.html http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Dare+Bioscience%2C+Inc.++++++++++++++++/26580286.html Mon, 01 Jun 2026 09:00:00 -0400 DARE O.02823105